吉利德科学Gilead Sciences (GILD) 2002年年度报告「NASDAQ」.pdf

1、FORM 10-K GILEAD SCIENCES INC(Annual Report)Filed 3/14/2003 For Period Ending 12/31/2002Address333 LAKESIDE DRFOSTER CITY,California 94404Telephone650-574-3000 CIK0000882095IndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31 QuickLinks-Click here to rapidly navigate through this document SEC

2、URITIES AND EXCHANGE COMMISSION Washington,D.C.20549 FORM 10-K Commission File No.0-19731 GILEAD SCIENCES,INC.(Exact name of registrant as specified in its charter)SECURITIES REGISTERED PURSUANT TO SECTION 12(b)OF THE ACT:NONE SECURITIES REGISTERED PURSUANT TO SECTION 12(g)OF THE ACT:COMMON STOCK$.0

3、01 PAR VALUE (Title of Class)Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the Registrant was required to file such reports),and(2)

4、has been subject to such filing requirements for the past 90 days.Yes?No?Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K(Section 229.405 of this chapter)is not contained herein,and will not be contained,to the best of registrants knowledge,in definiti

5、ve proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.?Indicate by check mark whether registrant is an accelerated filer(as defined in Rule 12B-2 of the Act).Yes?No?(Mark One)?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE

6、SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2002 or?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware (State or other jurisdiction of incorporation or organization)94-3047598 (I.R.S.Employer Id